218 related articles for article (PubMed ID: 24698164)
21. Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.
Tsujino T; Komura K; Matsunaga T; Yoshikawa Y; Takai T; Uchimoto T; Saito K; Tanda N; Oide R; Minami K; Uehara H; Jeong SH; Taniguchi K; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Azuma H
Ann Surg Oncol; 2017 Sep; 24(9):2787-2793. PubMed ID: 28643013
[TBL] [Abstract][Full Text] [Related]
22. Preoperative serum total cholesterol is a predictor of prognosis in patients with renal cell carcinoma: a meta- analysis of observational studies.
Li B; Huang D; Zheng H; Cai Q; Guo Z; Wang S
Int Braz J Urol; 2020; 46(2):158-168. PubMed ID: 31961621
[TBL] [Abstract][Full Text] [Related]
23. Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma.
Huang J; Feldman AS; Dong L; Cornejo K; Liu Q; Dahl DM; Wu S; Blute ML; Huang Y; Wu CL
Clin Genitourin Cancer; 2015 Oct; 13(5):e353-60. PubMed ID: 25998556
[TBL] [Abstract][Full Text] [Related]
24. Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma.
Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
Int J Clin Oncol; 2018 Feb; 23(1):142-150. PubMed ID: 28791497
[TBL] [Abstract][Full Text] [Related]
25. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival.
Vasudev NS; Brown JE; Brown SR; Rafiq R; Morgan R; Patel PM; O'Donnell D; Harnden P; Rogers M; Cocks K; Anderson K; Paul A; Eardley I; Selby PJ; Banks RE
Clin Cancer Res; 2008 Mar; 14(6):1775-81. PubMed ID: 18347179
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy.
Peng D; Zhang CJ; Tang Q; Zhang L; Yang KW; Yu XT; Gong Y; Li XS; He ZS; Zhou LQ
BMC Urol; 2018 Mar; 18(1):20. PubMed ID: 29544476
[TBL] [Abstract][Full Text] [Related]
28. Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).
Brookman-May SD; May M; Shariat SF; Novara G; Zigeuner R; Cindolo L; De Cobelli O; De Nunzio C; Pahernik S; Wirth MP; Longo N; Simonato A; Serni S; Siracusano S; Volpe A; Morgia G; Bertini R; Dalpiaz O; Stief C; Ficarra V; ; ;
BJU Int; 2013 Nov; 112(7):909-16. PubMed ID: 23890378
[TBL] [Abstract][Full Text] [Related]
29. A novel prognostic model for patients with sarcomatoid renal cell carcinoma.
Zhang BY; Thompson RH; Lohse CM; Leibovich BC; Boorjian SA; Cheville JC; Costello BA
BJU Int; 2015 Mar; 115(3):405-11. PubMed ID: 24730416
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
31. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
32. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
[TBL] [Abstract][Full Text] [Related]
33. The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy.
Życzkowski M; Rajwa P; Gabrys E; Jakubowska K; Jantos E; Paradysz A
Clin Genitourin Cancer; 2018 Jun; 16(3):e677-e683. PubMed ID: 29339043
[TBL] [Abstract][Full Text] [Related]
34. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
Brookman-Amissah S; Kendel F; Spivak I; Pflanz S; Roigas J; Klotz T; May M
BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527
[TBL] [Abstract][Full Text] [Related]
35. The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
Bezan A; Mrsic E; Krieger D; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
J Urol; 2015 Jul; 194(1):30-5. PubMed ID: 25623738
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Significance of Blood Type A in Patients with Renal Cell Carcinoma.
Ko K; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
Urol J; 2016 Aug; 13(4):2765-72. PubMed ID: 27576883
[TBL] [Abstract][Full Text] [Related]
37. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
38. Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.
Kawaciuk I; Hyrsl L; Dusek P; Jarolim L; Schmidt M; Kaliska V; Chocholaty M; Vesely S
Scand J Urol Nephrol; 2008; 42(5):406-11. PubMed ID: 18932106
[TBL] [Abstract][Full Text] [Related]
39. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.
Sengupta S; Lohse CM; Cheville JC; Leibovich BC; Thompson RH; Webster WS; Frank I; Zincke H; Blute ML; Kwon ED
Cancer; 2006 Jan; 106(2):304-12. PubMed ID: 16353202
[TBL] [Abstract][Full Text] [Related]
40. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
